TERPENICOL Antifungal Cream Recalled for CGMP Deviations
Blaine Labs Inc is recalling TERPENICOL Antifungal Cream due to CGMP deviations: the firm discontinued required stability testing for products still within expiry dates. The recall affects 22,143 bottles distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard relates to a manufacturing practice deviation (discontinued stability testing) rather than confirmed product contamination or defect, making it a precautionary, moderate-severity action.
Plain-English summary
Blaine Labs Inc is recalling TERPENICOL Antifungal Cream (Undecylenic Acid 13%) nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The firm discontinued required stability testing for products currently on the market that are still within their expiration dates.
The recalled product is TERPENICOL Antifungal Cream in 1.0 oz (28 g) bottles. The recall involves 22,143 bottles from Lots BL3431R (Exp Date 10/13/26) and BL3528 (Exp Date 08/30/2027), manufactured by Blaine Labs, Inc., located at 11037 Lockport Place, Santa Fe Springs, CA 90670 (NDC 63347-601-01).
Consumers in possession of the recalled product should stop using it and contact the recalling firm for further instructions. The FDA is monitoring the situation. For more information, visit the FDA's drug recalls webpage.
The recalled product
- Product
- TERPENICOL (UNDECYLENIC ACID)
- Brand
- TERPENICOL
- Manufacturer
- Blaine Labs Inc
- Category
- Drug — Topical Antifungal / OTC
- Affected units
- 22,143
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots BL3431R
- Exp Date 10/13/26 & BL3528
- Exp Date 08/30/2027.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Blaine Labs Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same brand · TERPENICOL
- ModerateTerpenicol Antifungal Solution Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-08
Same manufacturer · Blaine Labs Inc
See all →- ModerateRevitaderm Wound Care Benzalkonium Chloride OTC Drug Recall
FDA (Drugs) · 2026-07-08
- Moderatevite20 Antifungal Cream recalled due to stability testing deviations
FDA (Drugs) · 2026-07-08
- ModerateFungal Fusion antifungal kit recalled for discontinued stability testing
FDA (Drugs) · 2026-07-08
- ModerateTRIPENICOL S Antifungal Solution Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateTridergel Benzalkonium Chloride Wound Care Gel Recalled
FDA (Drugs) · 2026-07-08
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- HighFluocinonide Cream Recalled for Manufacturing Compliance and Stability Deviations
FDA (Drugs) · 2022-03-30
- ModerateGentamicin Sulfate Cream Recalled Due to Manufacturing Practice Violations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Lotion Recalled for cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- HighFDA Recalls Betamethasone Dipropionate Lotion Due to Manufacturing Deviations
FDA (Drugs) · 2022-03-30
- ModerateGentamicin Sulfate Cream USP 0.1% Recalled for cGMP Deviations
FDA (Drugs) · 2022-03-30